Long-term and latent side effects of specific cancer types

N Gegechkori, L Haines, JJ Lin - Medical Clinics, 2017 - medical.theclinics.com
There are currently more than 15 million cancer survivors in the United States, and it is
estimated that with improved treatment and early detection, the number of cancer survivors …

Bone metastases

RE Coleman, J Brown, I Holen - Abeloff's clinical oncology, 2020 - Elsevier
Bone metastasis is a major cause of morbidity in persons with cancer. Complications include
pain, impaired mobility, pathological fracture, spinal cord compression, cranial nerve …

The biology of bone metastasis

M Esposito, T Guise, Y Kang - Cold Spring …, 2018 - perspectivesinmedicine.cshlp.org
Bone metastasis, or the development of secondary tumors within the bone of cancer
patients, is a debilitating and incurable disease. Despite its morbidity, the biology of bone …

Monocyte chemoattractant protein-1 (MCP-1/CCL2) drives activation of bone remodelling and skeletal metastasis

BS Mulholland, MR Forwood, NA Morrison - Current osteoporosis reports, 2019 - Springer
Abstract Purpose of Review The purpose of this review is to explore the role of monocyte
chemoattractant protein-1 (MCP-1 or CCL2) in the processes that underpin bone …

Preservation of muscle mass as a strategy to reduce the toxic effects of cancer chemotherapy on body composition

F Pin, ME Couch, A Bonetto - Current opinion in supportive and …, 2018 - journals.lww.com
Muscle wasting often occurs as a consequence of anticancer treatments and is indicative of
worse outcomes and poor quality of life in cancer patients. Accurate assessment of body …

Low-modulus biomedical Ti–30Nb–5Ta–3Zr additively manufactured by Selective Laser Melting and its biocompatibility

JP Luo, JF Sun, YJ Huang, JH Zhang, YD Zhang… - Materials Science and …, 2019 - Elsevier
Low Young's modulus titanium alloys, such as Ti-30Nb-5Ta-3Zr (TNTZ) of this study, were
promising biocompatible implant materials. In this work, TNTZ samples with relative density …

From latency to overt bone metastasis in breast cancer: potential for treatment and prevention

F Salvador, A Llorente, RR Gomis - The Journal of pathology, 2019 - Wiley Online Library
Bone metastasis is present in a high percentage of breast cancer (BCa) patients with distant
disease, especially in those with the estrogen receptor‐positive (ER+) subtype. Most cells …

Understanding sex differences in the regulation of cancer-induced muscle wasting

RN Montalvo, BR Counts… - Current opinion in …, 2018 - journals.lww.com
Understanding sex differences in the regulation of cancer-in... : Current Opinion in Supportive
and Palliative Care Understanding sex differences in the regulation of cancer-induced muscle …

[HTML][HTML] Apigenin enhances skeletal muscle hypertrophy and myoblast differentiation by regulating Prmt7

YJ Jang, HJ Son, YM Choi, J Ahn, CH Jung, TY Ha - Oncotarget, 2017 - ncbi.nlm.nih.gov
Apigenin, a natural flavone abundant in various plant-derived foods including parsley and
celery, has been shown to prevent inflammation and inflammatory diseases. However, the …

The bone–muscle connection in breast cancer: implications and therapeutic strategies to preserve musculoskeletal health

TJ Ballinger, WR Thompson, TA Guise - Breast Cancer Research, 2022 - Springer
Breast cancer and its therapies frequently result in significant musculoskeletal morbidity.
Skeletal complications include bone metastases, pain, bone loss, osteoporosis, and fracture …